I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Millward, Michael
454
results:
Format
Online (454)
Mediatypes
Articles (Online) (257)
Bookchapter (Online) (5)
OpenAccess-fulltext (190)
Audio (Online) (2)
Sorted by: Relevance
Sorted by: Year
?
1
Time-course RNAseq data of murine AB1 mesothelioma and Renc..:
Chin, Wee Loong
;
Zemek, Rachael M.
;
Tilsed, Caitlin M.
...
Scientific Data. 11 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1038/..
?
2
Immune checkpoint therapy responders display early clonal e..:
Kidman, Joel
;
Zemek, Rachael M.
;
Sidhom, John-William
...
OncoImmunology. 13 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1080/..
?
3
Phase I studies of davoceticept (ALPN-202), a PD-L1-depende..:
Davar, Diwakar
;
Cavalcante, Ludimila
;
Lakhani, Nehal
...
Journal for ImmunoTherapy of Cancer. 12 (2024) 8 - p. e009474 , 2024
Link:
https://doi.org/10.1136/..
?
4
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III/..:
Larkin, James
;
Del Vecchio, Michele
;
Mandalá, Mario
...
Clinical Cancer Research. 29 (2023) 17 - p. 3352-3361 , 2023
Link:
https://doi.org/10.1158/..
?
5
A phase 1a/1b first-in-human study (COMPASSION-01) evaluati..:
Frentzas, Sophia
;
Gan, Hui K.
;
Cosman, Rasha
...
Cell Reports Medicine. 4 (2023) 11 - p. 101242 , 2023
Link:
https://doi.org/10.1016/..
?
6
Detection of metastases using circulating tumour DNA in uve..:
Beasley, Aaron B.
;
de Bruyn, Daniël P.
;
Calapre, Leslie
...
Journal of Cancer Research and Clinical Oncology. 149 (2023) 16 - p. 14953-14963 , 2023
Link:
https://doi.org/10.1007/..
?
7
Detectable ctDNA at the time of treatment cessation of ipil..:
Warburton, Lydia
;
Reid, Anna
;
Amanuel, Benhur
...
Frontiers in Oncology. 13 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
8
BRAF inhibitor cessation prior to disease progression in me..:
Lee, Joanna
;
Ahmed, Tasnia
;
Maurichi, Andrea
...
European Journal of Cancer. 179 (2023) - p. 87-97 , 2023
Link:
https://doi.org/10.1016/..
?
9
Temporally restricted activation of IFNβ signaling underlie..:
Zemek, Rachael M.
;
Chin, Wee Loong
;
Fear, Vanessa S.
...
Nature Communications. 13 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1038/..
?
10
Retinoic Acid Induces an IFN-Driven Inflammatory Tumour Mic..:
Tilsed, Caitlin M.
;
Casey, Thomas H.
;
de Jong, Emma
...
Frontiers in Oncology. 12 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
11
ATX-101, a cell-penetrating protein targeting PCNA, can be ..:
Lemech, Charlotte Rose
;
Kichenadasse, Ganessan
;
Marschner, Jens-Peter
...
Oncogene. 42 (2022) 7 - p. 541-544 , 2022
Link:
https://doi.org/10.1038/..
?
12
Adjuvant nivolumab versus ipilimumab (CheckMate 238 trial):..:
Larkin, James
;
Weber, Jeffrey
;
Del Vecchio, Michele
...
European Journal of Cancer. 173 (2022) - p. 285-296 , 2022
Link:
https://doi.org/10.1016/..
?
13
Human leucocyte antigen genotype association with the devel..:
Abed, Afaf
;
Law, Ngie
;
Calapre, Leslie
...
European Journal of Cancer. 172 (2022) - p. 98-106 , 2022
Link:
https://doi.org/10.1016/..
?
14
Powering single-cell genomics to unravel circulating tumour..:
Acheampong, Emmanuel
;
Morici, Michael
;
Abed, Afaf
...
Journal of Cancer Research and Clinical Oncology. 149 (2022) 5 - p. 1941-1950 , 2022
Link:
https://doi.org/10.1007/..
?
15
Sunvozertinib, a Selective EGFR Inhibitor for Previously Tr..:
Wang, Mengzhao
;
Yang, James Chih-Hsin
;
Mitchell, Paul L.
...
Cancer Discovery. 12 (2022) 7 - p. 1676-1689 , 2022
Link:
https://doi.org/10.1158/..
1-15